Birdwatch Note
2025-02-01 21:20:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The only FDA-approved administration of tirzepatide is via under-the-skin injection. Oral administration of tirzepatide is not approved by the FDA to treat any condition. https://investor.lilly.com/news-releases/news-release-details/open-letter-eli-lilly-and-company-regarding-certain-practices
Written by 1DF87FBC3D4050F4B5B0836C40FFE7F009140AF98A0ECB8EDF0067DD46D902AB
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1885097495820460463
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1885800536550613313
- noteId - 1885800536550613313
- participantId -
- noteAuthorParticipantId - 1DF87FBC3D4050F4B5B0836C40FFE7F009140AF98A0ECB8EDF0067DD46D902AB Participant Details
- createdAtMillis - 1738444859051
- tweetId - 1885097495820460463
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The only FDA-approved administration of tirzepatide is via under-the-skin injection. Oral administration of tirzepatide is not approved by the FDA to treat any condition. https://investor.lilly.com/news-releases/news-release-details/open-letter-eli-lilly-and-company-regarding-certain-practices
Note Ratings
| rated at | rated by | |
| 2025-02-04 17:20:52 -0600 | Rating Details | |
| 2025-02-05 08:57:34 -0600 | Rating Details | |
| 2025-02-10 15:20:51 -0600 | Rating Details | |
| 2025-02-10 12:31:14 -0600 | Rating Details | |
| 2025-02-10 00:21:44 -0600 | Rating Details | |
| 2025-02-09 20:39:26 -0600 | Rating Details | |
| 2025-02-09 14:25:50 -0600 | Rating Details | |
| 2025-02-11 19:54:49 -0600 | Rating Details | |
| 2025-02-13 15:40:13 -0600 | Rating Details | |
| 2025-02-12 18:09:24 -0600 | Rating Details | |
| 2025-02-13 14:40:17 -0600 | Rating Details |